Curcumin modulates α-synuclein aggregation and toxicity

ACS Chemical Neuroscience

Volumn 4, Issue 3, 2013, Pages 393-407

  Singh, Pradeep K ^a   Kotia, Vasudha ^a   Ghosh, Dhiman ^a   Mohite, Ganesh M ^a   Kumar, Ashutosh ^a   Maji, Samir K ^a  

^a INDIAN INSTITUTE OF TECHNOLOGY BOMBAY   (India)

Author keywords

synuclein; amyloid; Curcumin; oligomers; Parkinson's disease; toxicity

Indexed keywords

ALPHA SYNUCLEIN; CURCUMIN; OLIGOMER; POLYPHENOL DERIVATIVE;

ACCELERATION; ARTICLE; BINDING ASSAY; CIRCULAR DICHROISM; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG DETERMINATION; GEL PERMEATION CHROMATOGRAPHY; HUMAN; HUMAN CELL; IN VITRO STUDY; MOLECULAR WEIGHT; MORPHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; OLIGOMERIZATION; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN PURIFICATION;

ALPHA-SYNUCLEIN; CELL LINE, TUMOR; CURCUMIN; HUMANS; PARKINSON DISEASE; PROTEIN BINDING;

EID: 84875542895     PISSN: None     EISSN: 19487193     Source Type: Journal    
DOI: 10.1021/cn3001203     Document Type: Article

References (76)

1. Cookson, M. R. (2005) The biochemistry of Parkinson's disease Annu. Rev. Biochem. 74, 29-52
2. Lansbury, P. T. and Brice, A. (2002) Genetics of Parkinson's disease and biochemical studies of implicated gene products-Commentary Curr. Opin Cell. Biol. 14, 653-660
3. Feany, M. B. (2000) Studying human neurodegenerative diseases in flies and worms J. Neuropathol. Exp. Neurol. 59, 847-856
4. Conway, K. A., Harper, J. D., and Lansbury, P. T. (1998) Accelerated in vitro fibril formation by a mutant α-synuclein linked to early-onset Parkinson disease Nat. Med. 4, 1318-1320
5. Conway, K. A., Lee, S. J., Rochet, J. C., Ding, T. T., Williamson, R. E., and Lansbury, P. T. (2000) Acceleration of oligomerization, not fibrillization, is a shared property of both a-synuclein mutations linked to early-onset Parkinson's disease: Implications for pathogenesis and therapy Proc. Natl. Acad. Sci. U.S.A. 97, 571-576
6. Uversky, V. N., Lee, H. J., Li, J., Fink, A. L., and Lee, S. J. (2001) Stabilization of partially folded conformation during α-synuclein oligomerization in both purified and cytosolic preparations J. Biol. Chem. 276, 43495-43498
7. Goldberg, M. S. and Lansbury, P. T. (2000) Is there a cause-and-effect relationship between α-synuclein fibrillization and Parkinson's disease? Nat. Cell Biol. 2, E115-E119
8. Karpinar, D. P., Balija, M. B., Kugler, S., Opazo, F., Rezaei-Ghaleh, N., Wender, N., Kim, H. Y., Taschenberger, G., Falkenburger, B. H., Heise, H., Kumar, A., Riedel, D., Fichtner, L., Voigt, A., Braus, G. H., Giller, K., Becker, S., Herzig, A., Baldus, M., Jackle, H., Eimer, S., Schulz, J. B., Griesinger, C., and Zweckstetter, M. (2009) Pre-fibrillar α-synuclein variants with impaired β-structure increase neurotoxicity in Parkinson's disease models EMBO J. 28, 3256-3268
9. Winner, B., Jappelli, R., Maji, S. K., Desplats, P. A., Boyer, L., Aigner, S., Hetzer, C., Loher, T., Vilar, M., Campioni, S., Tzitzilonis, C., Soragni, A., Jessberger, S., Mira, H., Consiglio, A., Pham, E., Masliah, E., Gage, F. H., and Riek, R. (2011) In vivo demonstration that α-synuclein oligomers are toxic Proc. Natl. Acad. Sci. U.S.A. 108, 4194-4199
10. Martin, Z. S., Neugebauer, V., Dineley, K. T., Kayed, R., Zhang, W., Reese, L. C., and Taglialatela, G. (2012) α-Synuclein oligomers oppose long-term potentiation and impair memory through a calcineurin-dependent mechanism: relevance to human synucleopathic diseases J. Neurochem. 120, 440-452
11. Danzer, K. M., Haasen, D., Karow, A. R., Moussaud, S., Habeck, M., Giese, A., Kretzschmar, H., Hengerer, B., and Kostka, M. (2007) Different species of α-synuclein oligomers induce calcium influx and seeding J. Neurosci. 27, 9220-9232
12. Lazo, N. D., Maji, S. K., Fradinger, E. A., Bitan, G., and Teplow, D. B. (2005) The Amyloid β Protein. In Amyloid proteins: The β-sheet conformation and disease (Sipe, J. D., Ed.), pp 384-491, Wiley-VCH Publishers, Weinheim, Germany.
13. Mason, J. M., Kokkoni, N., Stott, K., and Doig, A. J. (2003) Design strategies for anti-amyloid agents Curr. Opin. Struct. Biol. 13, 526-532
14. Cohen, F. E. and Kelly, J. W. (2003) Therapeutic approaches to protein-misfolding diseases Nature 426, 905-909
15. Hong, D. P., Fink, A. L., and Uversky, V. N. (2008) Structural characteristics of α-synuclein oligomers stabilized by the flavonoid baicalein J. Mol. Biol. 383, 214-223
16. El-Agnaf, O. M., Paleologou, K. E., Greer, B., Abogrein, A. M., King, J. E., Salem, S. A., Fullwood, N. J., Benson, F. E., Hewitt, R., Ford, K. J., Martin, F. L., Harriott, P., Cookson, M. R., and Allsop, D. (2004) A strategy for designing inhibitors of α-synuclein aggregation and toxicity as a novel treatment for Parkinson's disease and related disorders FASEB J. 18, 1315-1317
17. Masuda, M., Suzuki, N., Taniguchi, S., Oikawa, T., Nonaka, T., Iwatsubo, T., Hisanaga, S., Goedert, M., and Hasegawa, M. (2006) Small molecule inhibitors of α-synuclein filament assembly Biochemistry 45, 6085-6094
18. Lamberto, G. R., Binolfi, A., Orcellet, M. L., Bertoncini, C. W., Zweckstetter, M., Griesinger, C., and Fernandez, C. O. (2009) Structural and mechanistic basis behind the inhibitory interaction of PcTS on α-synuclein amyloid fibril formation Proc. Natl. Acad. Sci. U.S.A. 106, 21057-21062
19. Ehrnhoefer, D. E., Bieschke, J., Boeddrich, A., Herbst, M., Masino, L., Lurz, R., Engemann, S., Pastore, A., and Wanker, E. E. (2008) EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers Nat. Struct. Mol. Biol. 15, 558-566
20. Masuda, M., Hasegawa, M., Nonaka, T., Oikawa, T., Yonetani, M., Yamaguchi, Y., Kato, K., Hisanaga, S., and Goedert, M. (2009) Inhibition of α-synuclein fibril assembly by small molecules: analysis using epitope-specific antibodies FEBS Lett. 583, 787-791
21. Zhu, M., Rajamani, S., Kaylor, J., Han, S., Zhou, F., and Fink, A. L. (2004) The flavonoid baicalein inhibits fibrillation of α-synuclein and disaggregates existing fibrils J. Biol. Chem. 279, 26846-26857
22. Rao, J. N., Dua, V., and Ulmer, T. S. (2008) Characterization of α-synuclein interactions with selected aggregation-inhibiting small molecules Biochemistry 47, 4651-4656
23. Bieschke, J., Russ, J., Friedrich, R. P., Ehrnhoefer, D. E., Wobst, H., Neugebauer, K., and Wanker, E. E. (2010) EGCG remodels mature α-synuclein and amyloid-beta fibrils and reduces cellular toxicity Proc. Natl. Acad. Sci. U.S.A. 107, 7710-7715
24. Caruana, M., Hogen, T., Levin, J., Hillmer, A., Giese, A., and Vassallo, N. (2011) Inhibition and disaggregation of α-synuclein oligomers by natural polyphenolic compounds FEBS Lett. 585, 1113-1120
25. Ferreira, N., Saraiva, M. J., and Almeida, M. R. (2011) Natural polyphenols inhibit different steps of the process of transthyretin (TTR) amyloid fibril formation FEBS Lett. 585, 2424-2430
26. Hafner-Bratkovic, I., Gaspersic, J., Smid, L. M., Bresjanac, M., and Jerala, R. (2008) Curcumin binds to the α-helical intermediate and to the amyloid form of prion protein-a new mechanism for the inhibition of PrP(Sc) accumulation J. Neurochem. 104, 1553-1564
27. Porat, Y., Abramowitz, A., and Gazit, E. (2006) Inhibition of amyloid fibril formation by polyphenols: structural similarity and aromatic interactions as a common inhibition mechanism Chem. Biol. Drug. Des. 67, 27-37
28. Goel, A., Kunnumakkara, A. B., and Aggarwal, B. B. (2008) Curcumin as ″Curecumin″: from kitchen to clinic Biochem. Pharmacol. 75, 787-809
29. Cole, G. M., Teter, B., and Frautschy, S. A. (2007) Neuroprotective effects of curcumin Adv. Exp. Med. Biol. 595, 197-212
30. Lim, G. P., Chu, T., Yang, F. S., Beech, W., Frautschy, S. A., and Cole, G. M. (2001) The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse J. Neurosci. 21, 8370-8377
31. Yang, F., Lim, G. P., Begum, A. N., Ubeda, O. J., Simmons, M. R., Ambegaokar, S. S., Chen, P. P., Kayed, R., Glabe, C. G., Frautschy, S. A., and Cole, G. M. (2005) Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo J. Biol. Chem. 280, 5892-5901
32. Khuwaja, G., Khan, M. M., Ishrat, T., Ahmad, A., Raza, S. S., Ashafaq, M., Javed, H., Khan, M. B., Khan, A., Vaibhav, K., Safhi, M. M., and Islam, F. (2011) Neuroprotective effects of curcumin on 6-hydroxydopamine-induced Parkinsonism in rats: behavioral, neurochemical and immunohistochemical studies Brain Res. 1368, 254-263
33. Hickey, M. A., Zhu, C., Medvedeva, V., Lerner, R. P., Patassini, S., Franich, N. R., Maiti, P., Frautschy, S. A., Zeitlin, S., Levine, M. S., and Chesselet, M. F. (2012) Improvement of neuropathology and transcriptional deficits in CAG 140 knock-in mice supports a beneficial effect of dietary curcumin in Huntington's disease Mol. Neurodegener. 7, 12
34. Garcia-Alloza, M., Borrelli, L. A., Rozkalne, A., Hyman, B. T., and Bacskai, B. J. (2007) Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model J. Neurochem. 102, 1095-1104
35. Ahmad, B. and Lapidus, L. J. (2012) Curcumin prevents aggregation in α-synuclein by increasing reconfiguration rate J. Biol. Chem. 287, 9193-9199
36. Ono, K. and Yamada, M. (2006) Antioxidant compounds have potent anti-fibrillogenic and fibril-destabilizing effects for α-synuclein fibrils in vitro J. Neurochem. 97, 105-115
37. Pandey, N., Strider, J., Nolan, W. C., Yan, S. X., and Galvin, J. E. (2008) Curcumin inhibits aggregation of α-synuclein Acta Neuropathol. 115, 479-489
38. Liu, Z., Yu, Y., Li, X., Ross, C. A., and Smith, W. W. (2011) Curcumin protects against A53T α-synuclein-induced toxicity in a PC12 inducible cell model for Parkinsonism Pharmacol. Res. 63, 439-444
39. Wang, M. S., Boddapati, S., Emadi, S., and Sierks, M. R. (2010) Curcumin reduces α-synuclein induced cytotoxicity in Parkinson's disease cell model BMC Neurosci. 11, 57
40. Hudson, S. A., Ecroyd, H., Kee, T. W., and Carver, J. A. (2009) The thioflavin T fluorescence assay for amyloid fibril detection can be biased by the presence of exogenous compounds FEBS J. 276, 5960-5972
41. Rai, D., Singh, J. K., Roy, N., and Panda, D. (2008) Curcumin inhibits FtsZ assembly: an attractive mechanism for its antibacterial activity Biochem. J. 410, 147-155
42. Mosmann, T. (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays J. Immunol. Methods 65, 55-63
43. Behl, C., Davis, J. B., Lesley, R., and Schubert, D. (1994) Hydrogen peroxide mediates amyloid beta protein toxicity Cell 77, 817-827
44. Braga, C. A., Follmer, C., Palhano, F. L., Khattar, E., Freitas, M. S., Romao, L., Di Giovanni, S., Lashuel, H. A., Silva, J. L., and Foguel, D. (2011) The anti-Parkinsonian drug selegiline delays the nucleation phase of α-synuclein aggregation leading to the formation of nontoxic species J. Mol. Biol. 405, 254-273
45. Zhao, H., Joseph, J., Fales, H. M., Sokoloski, E. A., Levine, R. L., Vasquez-Vivar, J., and Kalyanaraman, B. (2005) Detection and characterization of the product of hydroethidine and intracellular superoxide by HPLC and limitations of fluorescence Proc. Natl. Acad. Sci. U.S.A. 102, 5727-5732
46. Cremades, N., Cohen, S. I., Deas, E., Abramov, A. Y., Chen, A. Y., Orte, A., Sandal, M., Clarke, R. W., Dunne, P., Aprile, F. A., Bertoncini, C. W., Wood, N. W., Knowles, T. P., Dobson, C. M., and Klenerman, D. (2012) Direct observation of the interconversion of normal and toxic forms of α-synuclein Cell 149, 1048-1059
47. Marimpietri, D., Nico, B., Vacca, A., Mangieri, D., Catarsi, P., Ponzoni, M., and Ribatti, D. (2005) Synergistic inhibition of human neuroblastoma- related angiogenesis by vinblastine and rapamycin Oncogene 24, 6785-6795
48. Vermes, I., Haanen, C., Steffens-Nakken, H., and Reutelingsperger, C. (1995) A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V J. Immunol. Methods 184, 39-51
49. Klunk, W. E., Jacob, R. F., and Mason, R. P. (1999) Quantifying amyloid β-peptide (Aβ) aggregation using the Congo Red-Aβ (CR-Aβ) spectrophotometric assay Anal. Biochem. 266, 66-76
50. Maji, S. K., Perrin, M. H., Sawaya, M. R., Jessberger, S., Vadodaria, K., Rissman, R. A., Singru, P. S., Nilsson, K. P., Simon, R., Schubert, D., Eisenberg, D., Rivier, J., Sawchenko, P., Vale, W., and Riek, R. (2009) Functional amyloids as natural storage of peptide hormones in pituitary secretory granules Science 325, 328-332
51. El-Agnaf, O. M. A. and Irvine, G. B. (2002) Aggregation and neurotoxicity of α-synuclein and related peptides Biochem. Soc. Trans. 30, 559-565
52. Sidhu, A., Wersinger, C., Moussa, C. E., and Vernier, P. (2004) The role of α-synuclein in both neuroprotection and neurodegeneration Ann. N.Y. Acad. Sci. 1035, 250-270
53. Grelle, G., Otto, A., Lorenz, M., Frank, R. F., Wanker, E. E., and Bieschke, J. (2011) Black tea theaflavins inhibit formation of toxic amyloid-β and α-synuclein fibrils Biochemistry 50, 10624-10636
54. Langer, F., Eisele, Y. S., Fritschi, S. K., Staufenbiel, M., Walker, L. C., and Jucker, M. (2011) Soluble Abeta seeds are potent inducers of cerebral beta-amyloid deposition J. Neurosci. 31, 14488-14495
55. Podlisny, M. B., Ostaszewski, B. L., Squazzo, S. L., Koo, E. H., Rydell, R. E., Teplow, D. B., and Selkoe, D. J. (1995) Aggregation of secreted amyloid beta-protein into sodium dodecyl sulfate-stable oligomers in cell culture J. Biol. Chem. 270, 9564-9570
56. Walsh, D. M., Tseng, B. P., Rydel, R. E., Podlisny, M. B., and Selkoe, D. J. (2000) The oligomerization of amyloid beta-protein begins intracellularly in cells derived from human brain Biochemistry 39, 10831-10839
57. Neumann, M., Kahle, P. J., Giasson, B. I., Ozmen, L., Borroni, E., Spooren, W., Muller, V., Odoy, S., Fujiwara, H., Hasegawa, M., Iwatsubo, T., Trojanowski, J. Q., Kretzschmar, H. A., and Haass, C. (2002) Misfolded proteinase K-resistant hyperphosphorylated α-synuclein in aged transgenic mice with locomotor deterioration and in human α-synucleinopathies J. Clin. Invest. 110, 1429-1439
58. Vilar, M., Chou, H. T., Luhrs, T., Maji, S. K., Riek-Loher, D., Verel, R., Manning, G., Stahlberg, H., and Riek, R. (2008) The fold of α-synuclein fibrils Proc. Natl. Acad. Sci. U.S.A. 105, 8637-8642
59. Bolognesi, B., Kumita, J. R., Barros, T. P., Esbjorner, E. K., Luheshi, L. M., Crowther, D. C., Wilson, M. R., Dobson, C. M., Favrin, G., and Yerbury, J. J. (2010) ANS binding reveals common features of cytotoxic amyloid species ACS Chem. Biol. 5, 735-740
60. Campioni, S., Mannini, B., Zampagni, M., Pensalfini, A., Parrini, C., Evangelisti, E., Relini, A., Stefani, M., Dobson, C. M., Cecchi, C., and Chiti, F. (2010) A causative link between the structure of aberrant protein oligomers and their toxicity Nat. Chem. Biol. 6, 140-147
61. Daban, J. R., Samso, M., and Bartolome, S. (1991) Use of Nile Red as a fluorescent probe for the study of the hydrophobic properties of protein-sodium dodecyl sulfate complexes in solution Anal. Biochem. 199, 162-168
62. Sackett, D. L. and Wolff, J. (1987) Nile Red as a polarity-sensitive fluorescent probe of hydrophobic protein surfaces Anal. Biochem. 167, 228-234
63. Fuchs, H. and Gessner, R. (2001) The result of equilibrium-constant calculations strongly depends on the evaluation method used and on the type of experimental errors Biochem. J. 359, 411-418
64. Eliezer, D., Kutluay, E., Bussell, R., and Browne, G. (2001) Conformational properties of α-synuclein in its free and lipid-associated states J. Mol. Biol. 307, 1061-1073
65. Munishkina, L. A., Phelan, C., Uversky, V. N., and Fink, A. L. (2003) Conformational behavior and aggregation of α-synuclein in organic solvents: Modeling the effects of membranes Biochemistry 42, 2720-2730
66. Anderson, V. L., Ramlall, T. F., Rospigliosi, C. C., Webb, W. W., and Eliezer, D. (2010) Identification of a helical intermediate in trifluoroethanol-induced α-synuclein aggregation Proc. Natl. Acad. Sci. U.S.A. 107, 18850-18855
67. Fezoui, Y. and Teplow, D. B. (2002) Kinetic studies of amyloid β-protein fibril assembly-Differential effects of α-helix stabilization J. Biol. Chem. 277, 36948-36954
68. Dairam, A., Fogel, R., Daya, S., and Limson, J. L. (2008) Antioxidant and iron-binding properties of curcumin, capsaicin, and S-allylcysteine reduce oxidative stress in rat brain homogenate J. Agric. Food Chem. 56, 3350-3356
69. Hamaguchi, T., Ono, K., and Yamada, M. (2010) REVIEW: Curcumin and Alzheimer's disease CNS Neurosci. Ther. 16, 285-297
70. Caesar, I., Jonson, M., Nilsson, K. P., Thor, S., and Hammarstrom, P. (2012) Curcumin promotes Aβ fibrillation and reduces neurotoxicity in transgenic Drosophila PLoS One 7, e31424
71. Hamaguchi, T., Ono, K., Murase, A., and Yamada, M. (2009) Phenolic compounds prevent Alzheimer's pathology through different effects on the amyloid-beta aggregation pathway Am. J. Pathol. 175, 2557-2565
72. Necula, M., Kayed, R., Milton, S., and Glabe, C. G. (2007) Small molecule inhibitors of aggregation indicate that amyloid β oligomerization and fibrillization pathways are independent and distinct J. Biol. Chem. 282, 10311-10324
73. Orlando, R. A., Gonzales, A. M., Royer, R. E., Deck, L. M., and Vander Jagt, D. L. (2012) A chemical analog of curcumin as an improved inhibitor of amyloid β oligomerization PLoS One 7, e31869
74. Volles, M. J. and Lansbury, P. T., Jr. (2007) Relationships between the Sequence of α-Synuclein and its Membrane Affinity, Fibrillization Propensity, and Yeast Toxicity J. Mol. Biol. 366, 1510-1522
75. Lee, H. J., Khoshaghideh, F., Patel, S., and Lee, S. J. (2004) Clearance of α-synuclein oligomeric intermediates via the lysosomal degradation pathway J. Neurosci. 24, 1888-1896
76. Amijee, H., Bate, C., Williams, A., Virdee, J., Jeggo, R., Spanswick, D., Scopes, D. I., Treherne, J. M., Mazzitelli, S., Chawner, R., Eyers, C. E., and Doig, A. J. (2012) The N-Methylated Peptide SEN304 Powerfully Inhibits Aβ(1-42) Toxicity by Perturbing Oligomer Formation Biochemistry 51, 8338-8352